These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34813691)

  • 21. A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes.
    Morrison AE; Chong K; Senior PA; Lam A
    PLoS One; 2022; 17(8):e0271096. PubMed ID: 35951597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol.
    Musolino G; Allen JM; Hartnell S; Wilinska ME; Tauschmann M; Boughton C; Campbell F; Denvir L; Trevelyan N; Wadwa P; DiMeglio L; Buckingham BA; Weinzimer S; Acerini CL; Hood K; Fox S; Kollman C; Sibayan J; Borgman S; Cheng P; Hovorka R
    BMJ Open; 2019 Jun; 9(6):e027856. PubMed ID: 31164368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do-It-Yourself Automated Insulin Delivery: A Leading Example of the Democratization of Medicine.
    Burnside M; Crocket H; Mayo M; Pickering J; Tappe A; de Bock M
    J Diabetes Sci Technol; 2020 Sep; 14(5):878-882. PubMed ID: 31876179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, safety, and user experience of DIY or open-source artificial pancreas systems: a systematic review.
    Asarani NAM; Reynolds AN; Elbalshy M; Burnside M; de Bock M; Lewis DM; Wheeler BJ
    Acta Diabetol; 2021 May; 58(5):539-547. PubMed ID: 33128136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Care of children and adolescents with type 1 diabetes: solutions for technical and psychosocial challenges].
    Raile K; Boss K; Braune K; Heinrich-Rohr M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jul; 63(7):856-863. PubMed ID: 32488460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.
    Tsoukas MA; Majdpour D; Yale JF; Fathi AE; Garfield N; Rutkowski J; Rene J; Legault L; Haidar A
    Lancet Digit Health; 2021 Nov; 3(11):e723-e732. PubMed ID: 34580055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility study of a bio-inspired artificial pancreas in adults with type 1 diabetes.
    Reddy M; Herrero P; El Sharkawy M; Pesl P; Jugnee N; Thomson H; Pavitt D; Toumazou C; Johnston D; Georgiou P; Oliver N
    Diabetes Technol Ther; 2014 Sep; 16(9):550-7. PubMed ID: 24801544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Open Source Closed-Loop Insulin Delivery Systems: A Clash of Cultures or Merging of Diverse Approaches?
    Barnard KD; Ziegler R; Klonoff DC; Braune K; Petersen B; Rendschmidt T; Finan D; Kowalski A; Heinemann L
    J Diabetes Sci Technol; 2018 Nov; 12(6):1223-1226. PubMed ID: 30079769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes.
    Lynch J; Kanapka LG; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro C; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):726-736. PubMed ID: 36173238
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety and effectiveness of do-it-yourself artificial pancreas system compared with continuous subcutaneous insulin infusions in combination with free style libre in people with type 1 diabetes.
    Patel R; Crabtree TSJ; Taylor N; Langeland L; Gazis AT; Mendis B; Wilmot EG; Idris I
    Diabet Med; 2022 May; 39(5):e14793. PubMed ID: 35034388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
    Brown SA; Kovatchev BP; Raghinaru D; Lum JW; Buckingham BA; Kudva YC; Laffel LM; Levy CJ; Pinsker JE; Wadwa RP; Dassau E; Doyle FJ; Anderson SM; Church MM; Dadlani V; Ekhlaspour L; Forlenza GP; Isganaitis E; Lam DW; Kollman C; Beck RW;
    N Engl J Med; 2019 Oct; 381(18):1707-1717. PubMed ID: 31618560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a novel continuous glucose monitoring guided system for adjustment of insulin dosing - PumpTune: a randomized controlled trial.
    Anderson D; Phelan H; Jones K; Smart C; Oldmeadow C; King B; Crock P
    Pediatr Diabetes; 2016 Nov; 17(7):478-482. PubMed ID: 26701831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability.
    Herrero P; Bondia J; Adewuyi O; Pesl P; El-Sharkawy M; Reddy M; Toumazou C; Oliver N; Georgiou P
    Comput Methods Programs Biomed; 2017 Jul; 146():125-131. PubMed ID: 28688482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do-It-Yourself Artificial Pancreas System Use in Pregnant Women With Type 1 Diabetes in a Real-World Setting: 2 Case Reports.
    Lemieux P; Yamamoto JM; Donovan LE
    Can J Diabetes; 2021 Dec; 45(8):804-808.e2. PubMed ID: 33648862
    [No Abstract]   [Full Text] [Related]  

  • 37. Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    ; Russell SJ; Beck RW; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Calhoun P; Wadwa RP; Buckingham B; Zhou K; Daniels M; Raskin P; White PC; Lynch J; Pettus J; Hirsch IB; Goland R; Buse JB; Kruger D; Mauras N; Muir A; McGill JB; Cogen F; Weissberg-Benchell J; Sherwood JS; Castellanos LE; Hillard MA; Tuffaha M; Putman MS; Sands MY; Forlenza G; Slover R; Messer LH; Cobry E; Shah VN; Polsky S; Lal R; Ekhlaspour L; Hughes MS; Basina M; Hatipoglu B; Olansky L; Bhangoo A; Forghani N; Kashmiri H; Sutton F; Choudhary A; Penn J; Jafri R; Rayas M; Escaname E; Kerr C; Favela-Prezas R; Boeder S; Trikudanathan S; Williams KM; Leibel N; Kirkman MS; Bergamo K; Klein KR; Dostou JM; Machineni S; Young LA; Diner JC; Bhan A; Jones JK; Benson M; Bird K; Englert K; Permuy J; Cossen K; Felner E; Salam M; Silverstein JM; Adamson S; Cedeno A; Meighan S; Dauber A
    N Engl J Med; 2022 Sep; 387(13):1161-1172. PubMed ID: 36170500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Home Use of an Artificial Beta Cell in Type 1 Diabetes.
    Thabit H; Tauschmann M; Allen JM; Leelarathna L; Hartnell S; Wilinska ME; Acerini CL; Dellweg S; Benesch C; Heinemann L; Mader JK; Holzer M; Kojzar H; Exall J; Yong J; Pichierri J; Barnard KD; Kollman C; Cheng P; Hindmarsh PC; Campbell FM; Arnolds S; Pieber TR; Evans ML; Dunger DB; Hovorka R
    N Engl J Med; 2015 Nov; 373(22):2129-2140. PubMed ID: 26379095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How It Started, How It Is Going: The Future of Artificial Pancreas Systems (Automated Insulin Delivery Systems).
    Lewis D
    J Diabetes Sci Technol; 2021 Nov; 15(6):1258-1261. PubMed ID: 34218717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
    Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.